FDAnews
www.fdanews.com/articles/142873-chelsea-therapeutics-announces-fda-advisory-committee-meeting-date-for-review-of-northera-nda

Chelsea Therapeutics Announces FDA Advisory Committee Meeting Date for Review of Northera NDA

January 3, 2012
Chelsea Therapeutics International announced that the FDA has scheduled a meeting of the Cardiovascular and Renal Drugs Advisory Committee on Feb. 23 to review the NDA for Northera (droxidopa).
Yahoo! Finance